We’ve entered a new era at Heartflow – reaffirming our commitment to transforming coronary artery disease (CAD) from the world’s leading cause of death into a manageable condition. Discover what it means to see CAD earlier with decisive insights to manage the disease throughout patients’ lives. Learn more here: https://xmrrwallet.com/cmx.plnkd.in/gAUCF6j4. #Heartflow #HeartHealth #FFRCT #Plaque #CCTA #YesCCT
Heartflow
Medical Equipment Manufacturing
Mountain View, California 38,652 followers
About us
Heartflow is the global leader in AI-driven coronary artery disease (CAD) management, transforming how CAD — the world’s leading cause of death — is diagnosed and treated. Our advanced technology generates personalized, precision 3D heart models from a single CT scan, providing clinicians with the clarity and confidence to deliver earlier, more effective treatments — transforming CAD into a disease that can be managed for life. Heartflow One is the only complete, non-invasive, precision coronary care platform providing patient insights throughout the guideline-directed CCTA pathway. The AI-driven platform — including Roadmap™ Analysis, FFRCT Analysis and Plaque Analysis — is supported by the ACC/AHA Chest Pain Guideline and backed by more than 600 peer-reviewed publications. With over 400,000 patients treated, more than 1,400 leading institutions adopting our solution, and 99.5% of U.S. lives covered — Heartflow is redefining the standard of coronary care. We're a global company, with employees across the United States, Europe and Japan. Our headquarters are in Mountain View, California, with additional offices in California, Texas, the UK and Japan. We believe CAD shouldn’t be a silent threat. We’re changing the story of CAD by making it screenable, diagnosable, and manageable — empowering clinicians to save lives and giving patients more time for what matters most.
- Website
-
http://xmrrwallet.com/cmx.pwww.heartflow.com
External link for Heartflow
- Industry
- Medical Equipment Manufacturing
- Company size
- 501-1,000 employees
- Headquarters
- Mountain View, California
- Type
- Privately Held
Locations
Employees at Heartflow
Updates
-
Join us at #ASPC2025, where Drs. Seth Shay Martin, Sarah Rinehart and Matthew Budoff will explore how AI-driven plaque quantification is transforming #CAD management by reshaping diagnosis, risk stratification, and treatment decisions for more personalized care. American Society for Preventive Cardiology (ASPC) #PlaqueAnalysis
-
Great news for patient access: UnitedHealthcare, the largest commercial insurer in the U.S., will cover Heartflow Plaque Analysis across all business lines, making our AI-driven technology even more accessible. This landmark policy expands coverage to patients starting October 1. Explore what this means for early detection and quantification of plaque as a major step in Heartflow’s vision to transform CAD into a disease that can be managed for life: https://xmrrwallet.com/cmx.plnkd.in/ge8dXDTZ #PatientAccess #CardiacImaging #HealthInsurance
-
Data from the landmark DECIDE Registry demonstrate the impact of Heartflow Plaque Analysis on coronary artery disease medical management. Learn more here: https://xmrrwallet.com/cmx.plnkd.in/gjgxx_nw #AdvancedImaging #CoronaryCare #SCCT2025
-
DECIDE Registry confirms clinical impact of Heartflow Plaque Analysis: More than 50% of patients had medical management changes. Sarah Rinehart, MD, Co-Lead PI of DECIDE, highlights the clinical significance of the data and how Plaque Analysis is reshaping decision-making in CAD management. Read the full announcement: https://xmrrwallet.com/cmx.plnkd.in/gjgxx_nw. #CoronaryCare #InnovationInHealthcare #SCCT2025
-
Exciting news for patient access to AI-driven Heartflow Plaque Analysis! Updated coverage guidelines for cardiac imaging will include Plaque Analysis effective this October, paving the way for broader payor coverage of this groundbreaking technology in the United States. Learn more about this milestone: https://xmrrwallet.com/cmx.plnkd.in/gw2U2afp #CardiacImaging #HealthInsurance
-
-
Attending #SCCT2025 in Montreal? Join us for the following exciting sessions, where product innovations and new clinical evidence from the DECIDE Registry will be presented. View the full schedule of sessions: https://xmrrwallet.com/cmx.plnkd.in/g9Sv_7iJ #PlaqueAnalysis #HealthcareInnovation
-
Congrats to Dr. Cian McCarthy! His work with Heartflow’s DECIDE Registry was recognized for enhancing CAD diagnosis, management and outcomes using #CCTA based analyses. We’re looking forward to celebrating this advancement in AI-powered care with the full presentation on July 18. Learn more: https://xmrrwallet.com/cmx.pow.ly/xXB250Wilxh #SCCT2025 #AIResearch
-
-
At #SCCT2025, we’re unveiling product innovations and new data that are redefining what’s possible in plaque imaging. More details: https://xmrrwallet.com/cmx.plnkd.in/g9Sv_7iJ Society of Cardiovascular Computed Tomography #PlaqueAnalysis #NewTechnology
-
-
Marking 15 years of progress in coronary care, we will present the final primary endpoint data from our landmark DECIDE Registry at #SCCT2025. Learn more here: https://xmrrwallet.com/cmx.plnkd.in/gK747irc #InnovationInCare #CoronaryCare
-